サマリー

非結核性抗酸菌症市場 2024-2028
非結核性抗酸菌症市場は、2023年から2028年にかけて43億3000万米ドルの成長が予測され、予測期間中のCAGRは5.66%で加速すると予測されます。当レポートでは、非結核性抗酸菌症市場の全体的な分析、市場規模および予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、世界的なNTMの有病率の増加、高齢者人口の増加、NTM感染に対する認識と診断の増加によって牽引されています。
Technavio社の非結核性抗酸菌症市場は以下のように分類されます：
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
製品別
- クラリスロマイシン
- アジスロマイシン
- リファンピン
- リファブチン
- その他
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間における非結核性抗酸菌症市場の成長を促進する主な理由の1つとして、非結核性抗酸菌症治療における精密医療の採用が増加していることを挙げている。また、新規ドラッグデリバリーシステムの台頭と併用療法への注目の高まりは、市場の大きな需要につながるでしょう。
本レポートでは、非結核性抗酸菌症市場について以下の分野をカバーしています：
- 非結核性抗酸菌症市場のサイジング
- 非結核性抗酸菌症市場予測
- 非結核性抗酸菌症市場産業分析
本レポートでは、非結核性抗酸菌症市場の主要ベンダーの詳細な分析を掲載しています。主要ベンダーには、Abbott Laboratories, Astellas Pharma Inc.Inc.、Pace Biotech、Pfizer Inc.、QIAGEN NV、Sanofi SA、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Zydus Lifesciences Ltd.などである。また、非結核性抗酸菌症市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/nontuberculous-mycobacterial-infections-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global nontuberculous mycobacterial infections market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global nontuberculous mycobacterial infections market 2018 - 2022 ($ billion)
o 4.2 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
o 4.3 Product Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o 6.4 Retail pharmacies - Market size and forecast 2023-2028
o Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 6.5 Online pharmacies - Market size and forecast 2023-2028
o Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ billion)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Clarithromycin - Market size and forecast 2023-2028
o Exhibit 52: Chart on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Clarithromycin - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Clarithromycin - Year-over-year growth 2023-2028 (%)
o 7.4 Azithromycin - Market size and forecast 2023-2028
o Exhibit 56: Chart on Azithromycin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Azithromycin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Azithromycin - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Azithromycin - Year-over-year growth 2023-2028 (%)
o 7.5 Rifampin - Market size and forecast 2023-2028
o Exhibit 60: Chart on Rifampin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Rifampin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Rifampin - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Rifampin - Year-over-year growth 2023-2028 (%)
o 7.6 Rifabutin - Market size and forecast 2023-2028
o Exhibit 64: Chart on Rifabutin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Rifabutin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Rifabutin - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Rifabutin - Year-over-year growth 2023-2028 (%)
o 7.7 Others - Market size and forecast 2023-2028
o Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.8 Market opportunity by Product
o Exhibit 72: Market opportunity by Product ($ billion)
o Exhibit 73: Data Table on Market opportunity by Product ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share by geography 2023-2028 (%)
o Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 UK - Market size and forecast 2023-2028
o Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.9 Japan - Market size and forecast 2023-2028
o Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.10 Germany - Market size and forecast 2023-2028
o Exhibit 107: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.11 China - Market size and forecast 2023-2028
o Exhibit 111: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 112: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 113: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 114: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 115: Market opportunity by geography ($ billion)
o Exhibit 116: Data Tables on Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 123: Abbott Laboratories - Overview
o Exhibit 124: Abbott Laboratories - Business segments
o Exhibit 125: Abbott Laboratories - Key news
o Exhibit 126: Abbott Laboratories - Key offerings
o Exhibit 127: Abbott Laboratories - Segment focus
o 12.4 Astellas Pharma Inc.
o Exhibit 128: Astellas Pharma Inc. - Overview
o Exhibit 129: Astellas Pharma Inc. - Product / Service
o Exhibit 130: Astellas Pharma Inc. - Key news
o Exhibit 131: Astellas Pharma Inc. - Key offerings
o 12.5 Cipla Ltd.
o Exhibit 132: Cipla Ltd. - Overview
o Exhibit 133: Cipla Ltd. - Business segments
o Exhibit 134: Cipla Ltd. - Key news
o Exhibit 135: Cipla Ltd. - Key offerings
o Exhibit 136: Cipla Ltd. - Segment focus
o 12.6 Glenmark Pharmaceuticals Ltd.
o Exhibit 137: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 138: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 139: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.7 Hikma Pharmaceuticals Plc
o Exhibit 140: Hikma Pharmaceuticals Plc - Overview
o Exhibit 141: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 142: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 143: Hikma Pharmaceuticals Plc - Segment focus
o 12.8 Insmed Inc.
o Exhibit 144: Insmed Inc. - Overview
o Exhibit 145: Insmed Inc. - Product / Service
o Exhibit 146: Insmed Inc. - Key offerings
o 12.9 Johnson and Johnson
o Exhibit 147: Johnson and Johnson - Overview
o Exhibit 148: Johnson and Johnson - Business segments
o Exhibit 149: Johnson and Johnson - Key news
o Exhibit 150: Johnson and Johnson - Key offerings
o Exhibit 151: Johnson and Johnson - Segment focus
o 12.10 Lupin Ltd.
o Exhibit 152: Lupin Ltd. - Overview
o Exhibit 153: Lupin Ltd. - Product / Service
o Exhibit 154: Lupin Ltd. - Key news
o Exhibit 155: Lupin Ltd. - Key offerings
o 12.11 Pfizer Inc.
o Exhibit 156: Pfizer Inc. - Overview
o Exhibit 157: Pfizer Inc. - Product / Service
o Exhibit 158: Pfizer Inc. - Key news
o Exhibit 159: Pfizer Inc. - Key offerings
o 12.12 QIAGEN NV
o Exhibit 160: QIAGEN NV - Overview
o Exhibit 161: QIAGEN NV - Product / Service
o Exhibit 162: QIAGEN NV - Key news
o Exhibit 163: QIAGEN NV - Key offerings
o 12.13 Sanofi SA
o Exhibit 164: Sanofi SA - Overview
o Exhibit 165: Sanofi SA - Business segments
o Exhibit 166: Sanofi SA - Key news
o Exhibit 167: Sanofi SA - Key offerings
o Exhibit 168: Sanofi SA - Segment focus
o 12.14 Sun Pharmaceutical Industries Ltd.
o Exhibit 169: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 170: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 171: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.15 Teva Pharmaceutical Industries Ltd.
o Exhibit 172: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 176: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.16 Viatris Inc.
o Exhibit 177: Viatris Inc. - Overview
o Exhibit 178: Viatris Inc. - Business segments
o Exhibit 179: Viatris Inc. - Key news
o Exhibit 180: Viatris Inc. - Key offerings
o Exhibit 181: Viatris Inc. - Segment focus
o 12.17 Zydus Lifesciences Ltd.
o Exhibit 182: Zydus Lifesciences Ltd. - Overview
o Exhibit 183: Zydus Lifesciences Ltd. - Business segments
o Exhibit 184: Zydus Lifesciences Ltd. - Key offerings
o Exhibit 185: Zydus Lifesciences Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 186: Inclusions checklist
o Exhibit 187: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 188: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 189: Research methodology
o Exhibit 190: Validation techniques employed for market sizing
o Exhibit 191: Information sources
o 13.5 List of abbreviations
o Exhibit 192: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global nontuberculous mycobacterial infections market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Product - Market share 2023-2028 (%)
Exhibits49: Data Table on Product - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Clarithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Clarithromycin - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Clarithromycin - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Azithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Azithromycin - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Azithromycin - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Azithromycin - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Rifampin - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Rifampin - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Rifampin - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Rifampin - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Rifabutin - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Rifabutin - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Rifabutin - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Rifabutin - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Product ($ billion)
Exhibits73: Data Table on Market opportunity by Product ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share by geography 2023-2028 (%)
Exhibits76: Data Table on Market share by geography 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity by geography ($ billion)
Exhibits116: Data Tables on Market opportunity by geography ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories - Overview
Exhibits124: Abbott Laboratories - Business segments
Exhibits125: Abbott Laboratories - Key news
Exhibits126: Abbott Laboratories - Key offerings
Exhibits127: Abbott Laboratories - Segment focus
Exhibits128: Astellas Pharma Inc. - Overview
Exhibits129: Astellas Pharma Inc. - Product / Service
Exhibits130: Astellas Pharma Inc. - Key news
Exhibits131: Astellas Pharma Inc. - Key offerings
Exhibits132: Cipla Ltd. - Overview
Exhibits133: Cipla Ltd. - Business segments
Exhibits134: Cipla Ltd. - Key news
Exhibits135: Cipla Ltd. - Key offerings
Exhibits136: Cipla Ltd. - Segment focus
Exhibits137: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits138: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits139: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits140: Hikma Pharmaceuticals Plc - Overview
Exhibits141: Hikma Pharmaceuticals Plc - Business segments
Exhibits142: Hikma Pharmaceuticals Plc - Key offerings
Exhibits143: Hikma Pharmaceuticals Plc - Segment focus
Exhibits144: Insmed Inc. - Overview
Exhibits145: Insmed Inc. - Product / Service
Exhibits146: Insmed Inc. - Key offerings
Exhibits147: Johnson and Johnson - Overview
Exhibits148: Johnson and Johnson - Business segments
Exhibits149: Johnson and Johnson - Key news
Exhibits150: Johnson and Johnson - Key offerings
Exhibits151: Johnson and Johnson - Segment focus
Exhibits152: Lupin Ltd. - Overview
Exhibits153: Lupin Ltd. - Product / Service
Exhibits154: Lupin Ltd. - Key news
Exhibits155: Lupin Ltd. - Key offerings
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: QIAGEN NV - Overview
Exhibits161: QIAGEN NV - Product / Service
Exhibits162: QIAGEN NV - Key news
Exhibits163: QIAGEN NV - Key offerings
Exhibits164: Sanofi SA - Overview
Exhibits165: Sanofi SA - Business segments
Exhibits166: Sanofi SA - Key news
Exhibits167: Sanofi SA - Key offerings
Exhibits168: Sanofi SA - Segment focus
Exhibits169: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits170: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits171: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits173: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits174: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits175: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits176: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits177: Viatris Inc. - Overview
Exhibits178: Viatris Inc. - Business segments
Exhibits179: Viatris Inc. - Key news
Exhibits180: Viatris Inc. - Key offerings
Exhibits181: Viatris Inc. - Segment focus
Exhibits182: Zydus Lifesciences Ltd. - Overview
Exhibits183: Zydus Lifesciences Ltd. - Business segments
Exhibits184: Zydus Lifesciences Ltd. - Key offerings
Exhibits185: Zydus Lifesciences Ltd. - Segment focus
Exhibits186: Inclusions checklist
Exhibits187: Exclusions checklist
Exhibits188: Currency conversion rates for US$
Exhibits189: Research methodology
Exhibits190: Validation techniques employed for market sizing
Exhibits191: Information sources
Exhibits192: List of abbreviations